CC

Caxton Corporation Portfolio holdings

AUM $9.85M
1-Year Est. Return 26.35%
This Quarter Est. Return
1 Year Est. Return
+26.35%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$9.85M
AUM Growth
+$4.77M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
13
New
Increased
Reduced
Closed

Top Buys

1
+$1.27M
2
+$1.11M
3
+$263K
4
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$80.2K

Top Sells

1
+$41.7K
2
+$13.2K
3
+$2.09K

Sector Composition

1 Healthcare 81.56%
2 Financials 3.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RZLT icon
1
Rezolute
RZLT
$789M
$7.15M 72.6%
1,603,986
+285,019
GLD icon
2
SPDR Gold Trust
GLD
$135B
$1.51M 15.32%
4,952
+3,654
BRK.B icon
3
Berkshire Hathaway Class B
BRK.B
$1.06T
$307K 3.12%
632
+165
ELVN icon
4
Enliven Therapeutics
ELVN
$1.27B
$263K 2.67%
+13,097
MNMD icon
5
MindMed
MNMD
$1.04B
$221K 2.24%
34,073
CMPX icon
6
Compass Therapeutics
CMPX
$731M
$113K 1.15%
43,465
BCAX
7
Bicara Therapeutics
BCAX
$997M
$102K 1.03%
10,941
KYTX icon
8
Kyverna Therapeutics
KYTX
$287M
$70.6K 0.72%
22,981
LXEO icon
9
Lexeo Therapeutics
LXEO
$517M
$69.7K 0.71%
17,332
-519
IKT icon
10
Inhibikase Therapeutics
IKT
$117M
$32K 0.32%
16,393
CNTX icon
11
Context Therapeutics
CNTX
$129M
$12.1K 0.12%
18,403
ACET icon
12
Adicet Bio
ACET
$152M
– –
-17,488
CRDF icon
13
Cardiff Oncology
CRDF
$146M
– –
-13,287